1. Home
  2. TRUP vs NEO Comparison

TRUP vs NEO Comparison

Compare TRUP & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trupanion Inc.

TRUP

Trupanion Inc.

HOLD

Current Price

$28.14

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$15.59

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRUP
NEO
Founded
2000
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2014
2008

Fundamental Metrics

Financial Performance
Metric
TRUP
NEO
Price
$28.14
$15.59
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$45.80
$13.38
AVG Volume (30 Days)
392.0K
3.0M
Earning Date
04-30-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
295.65
N/A
EPS
0.27
N/A
Revenue
$1,439,305,000.00
N/A
Revenue This Year
$11.79
$10.63
Revenue Next Year
$8.83
$9.73
P/E Ratio
$104.30
N/A
Revenue Growth
11.95
N/A
52 Week Low
$21.16
$5.65
52 Week High
$51.78
$16.45

Technical Indicators

Market Signals
Indicator
TRUP
NEO
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
TRUP
NEO

About TRUP Trupanion Inc.

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions. Geographically, the company operates in United States, which derives maximum revenue; and Canada and Others.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: